Presence of Anti-drug Antibodies Does Not Reduce the Efficacy of an Oral Anti-TNF Antibody in a Murine IBD Model

被引：0
|
作者：
Bhol, Kailash [1 ]
Erlich, Emma [1 ]
Lemos, Brenda [1 ]
Tracey, Daniel [1 ]
Hartman, Deborah [1 ]
Fox, Barbara [1 ]
机构：
[1] Avaxia Biol Inc, Lexington, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01810
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1810
引用
收藏
页码：S545 / S546
页数：2
相关论文
共 50 条
  • [31] Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease
    Guerra, Ivan
    Chaparro, Maria
    Bermejo, Fernando
    Gisbert, Javier P.
    CURRENT DRUG METABOLISM, 2014, 15 (09) : 875 - 881
  • [32] IMPACT OF BODY MASS INDEX (BMI) UPON ANTI-TNF TROUGH AND ANTI-DRUG ANTIBODY LEVELS
    Bond, A.
    Sager, K.
    Phillips, S.
    Asher, R.
    Jackson, R.
    Kneebone, A.
    Martin, K.
    Subramanian, S.
    GUT, 2015, 64 : A91 - A91
  • [33] Antibodies to anti-TNF therapy—consequences for IBD management
    Welmoed K. van Deen
    Daniel W. Hommes
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 446 - 448
  • [34] Anti-TNF drug and antidrug antibody level monitoring in IBD: a practical guide
    Hendy, Philip
    Hart, Ailsa
    Irving, Peter
    FRONTLINE GASTROENTEROLOGY, 2016, 7 (02) : 122 - 128
  • [35] Real World Experience in Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Lack of Anti-Drug Antibodies to Vedolizumab and Ustekinumab Compared to Anti-TNF Agents in IBD
    Glassner, Kerri L.
    Oglat, Ayah
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S342 - S343
  • [36] IBD Antibodies to anti-TNF therapy-consequences for IBD management
    van Deen, Welmoed K.
    Hommes, Daniel W.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (08) : 446 - 448
  • [37] Letter: predictive factors for treatment discontinuation in IBD-anti-TNF trough levels and anti-drug antibodies
    Demarzo, Maria Giulia
    Bodini, Giorgia
    Giuliana, Elisabetta
    Zentilin, Patrizia
    Giannini, Edoardo G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 536 - 537
  • [38] Prevalence and clinical implications of anti-drug antibody formation and serum drug levels among patients with IBD receiving anti-TNF therapy: A cross-sectional study
    Alghamdi, Ahmed
    Alahmari, Mohammed
    Aljohani, Khulood
    Alanazi, Aisha
    Al Ibrahim, Bashaar
    Alshowair, Mishal
    Tawfik, Marwa
    Alghamdi, Waleed
    Alanazi, Salman
    Alzayed, Faisal
    Alghamdi, Abdullah S.
    Bawazir, Abdullah
    Alhamidi, Hussam
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2025, 31 (02):
  • [39] Anti-TNF and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab
    Yanai, Henit
    Lichtenstein, Lev
    Assa, Amit
    Mazor, Yoav
    Weiss, Batia
    Levine, Arie
    Ron, Yulia
    Kopylov, Uri
    Bujanover, Yoram
    Rosenbach, Yoram
    Ungar, Bella
    Eliakim, Abraham R.
    Chowers, Yehuda
    Shamir, Raanan
    Fraser, Gerald
    Dotan, Iris
    Ben-Horin, Shomron
    GASTROENTEROLOGY, 2014, 146 (05) : S381 - S381
  • [40] REVERSAL OF ANTI-DRUG ANTIBODIES TO ANTI-TNF THERAPY WITH ADDITION OF IMMUNOMODULATORS: A SYSTEMIC REVIEW AND META-ANALYSIS
    Kucharski, Kimberly
    Kashani, Amir
    GASTROENTEROLOGY, 2023, 164 (06) : S655 - S655
12345